Maverick Medical AI News
7 articles
growth-positive
Maverick Medical AI Closes a $5M Seed Investment Round for Accelerating Development of its mCoder™ Artificial Intelligence Platform for Additional Clinical Domains
Maverick Medical AI has closed a $5 million seed investment from leading investors in the healthcare IT industry. The investment will be used to scale the companys R&D and sales teams and expand its solution for a wider range of clinical domains. Maverick offers a cutting-edge AI platform, mCoder™, that addresses the medical coding efficiency, accuracy, and capacity challenges in the healthcare revenue cycle. The platform has been validated and used by several leading U.S. healthcare providers. Maverick aims to expand its partnerships and customer base.
Investment
growth-positive
Maverick Medical AI's mCoder™ artificial Intelligence platform generates increased revenues for providers across all departments and specialties
Maverick Medical AI is rolling out its mCoder™ deep learning AI platform in the US healthcare market. The platform automates coding by converting unstructured text in patient charts to medical codes, increasing reimbursement billing and revenues. The uniqueness of the platform lies in its use of synthetic records, allowing it to adapt to cases with limited data. Maverick Medical AIs CEO highlights the need for coding solutions in the market and the companys differentiated solution. Initial collaborations with US healthcare providers have shown the economic value of mCoder™, with a 95% accuracy rate surpassing human coders. The solution can reduce costs and increase revenues by working independently or alongside coders. Maverick Medical AI was founded in 2017 and offers a multi-specialty platform for autonomously coding patient reports for reimbursement claims.
CustomersPartners
growth-positive
Maverick Medical AI Announces Elad Benjamin joins Board of Directors
Maverick Medical AI has announced the addition of Elad Benjamin to its Board of Directors. Elad brings over 20 years of executive-level experience in the Healthcare & Enterprise Software industry. He has held management roles in leading corporations such as Carestream Health and Lumenis, as well as in early-stage startups. Elad is currently the General Manager Radiology and AI Informatics at Philips. His addition to Maverick Medical AIs Board of Directors strengthens the companys position as it continues to grow. Maverick Medical AI is an early commercial-stage company offering a deep learning neural network platform for medical coding automation.
Management ChangesInvestment
growth-positive
Michael Brozino Joins Maverick Medical AI as Co-Founder and Chief Commercial Officer to Bring Clinical AI Cognition™ Tech to Market
Maverick Medical AI, a healthcare technology company, has announced the appointment of Michael Brozino as Co-Founder and Chief Commercial Officer. Brozino will be responsible for driving commercial growth and US expansion of the company. The company is focused on improving clinical data quality and analysis through its Clinical AI Cognition platform. Brozino brings over two decades of senior leadership experience in healthcare technology to the Maverick team. In late 2019, Maverick entered into its first commercial agreement with leading health management company US Health Systems (USHS).
Management ChangesExpand
growth-positive
Maverick Medical AI Announces Its First Commercial Deployment at USHS Health System to Automatically Detect Medicare Advantage Risk Factors
Maverick Medical AI has entered into a commercial agreement with US Health Systems (USHS) to expand the deployment of Mavericks software within the organization. The software, powered by Mavericks Clinical AI Cognition platform, accurately extracts chronic conditions and risk factors from primary care physician progress notes. The initial pilot achieved 98% accuracy. The softwares value-added approach mimics the way specialists read and understand clinical text. USHS expects the software to improve treatment for patients and increase revenues for the company. Maverick Medical AI was founded in 2017 and aims to meet unaddressed needs in the healthcare industry.
Partners
growth-positive
Maverick Medical AI Raises $700,000
Maverick Medical AI has raised $700,000 from The Time and the Israel Innovation Authority for the development of its medical AI-based solutions. The funding will be used to identify chronic diseases in elderly populations and implement the solutions with U.S. healthcare providers and insurers. The AI software system analyzes medical reports to identify clinical risk factors and provide actionable diagnoses. Maverick AI has attracted collaboration agreements with several U.S. hospitals and aims to improve the quality of life for the elderly through early disease detection.
InvestmentExpand
growth-positive
Maverick Medical AI Raises NIS 2.5 Million
Tel Aviv-based Maverick Medical AI Ltd. has raised NIS 2.5 million (approximately $675,000) from Israeli early-stage investor The Time, and the government’s tech investment arm Israel Innovation Authority. The company develops natural language processing and machine learning technologies that scan through medical records to identify clinical risk factors.
Investment
